Global Health

AFP                                                                                                                     Feb. 23, 2015
Los Angeles  - Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed Monday it was somewhat effective at saving lives if given early in the illness, but not later.

Early results from an Ebola trial using the experimental drug Avigan (favipiravir) show it is somewhat effective at saving lives if given early in the illness (AFP Photo/George Frey)

The antiviral treatment is being developed by the Japanese company Toyama Chemical, and has been shown safe and effective against some other viruses including influenza, West Nile and yellow fever.

An ongoing clinical trial in Guinea is testing the drug's use in patients with the Ebola virus, which causes severe vomiting, diarrhea and sometimes fatal bleeding.

Results from only 80 people are available so far, but they show that among those who received the drug early in their illness, 15 percent died of Ebola.

Read complete story.

Center for Global Development - cgdev.org -by Karen A. Grépin and Amanda Glassman - February 4, 2015

. . . In a new paper out today in the BMJ, Karen investigated the level and speed of the international response to the Ebola outbreak and contrasted it with the appeals made by international leaders to curb the spread of the disease. Contrary to widespread belief, Karen finds that, overall, the level of donations to the response were actually robust: as of December 31st, 2,104 donors had pledged almost $3 billion towards controlling the epidemic. Notably, this is actually larger than the official appeals for upwards of $1.5 billion. In addition, the data used underestimate total donations, in particular those given by the World Bank, which mobilized at least $1 billion in financing to help support affected countries.

BBC                                                                      Feb.23, 2015

Five UK Ebola nurses and doctors are under investigation by regulators, Public Health England says.

They are looking into the screening of medics who flew back to England on 28 December after treating patients in Sierra Leone.

                  Pauline Cafferkey was diagnosed with Ebola in December after volunteering work in Sierra Leone

On this flight was Scottish nurse Pauline Cafferkey - who developed Ebola - and some of her colleagues.

Questions have arisen over the health assessments and protocols that were followed.

Media reports have suggested Ms Cafferkey may have had signs of Ebola before leaving Sierra Leone but regulators have not commented on this.

http://m.bbc.com/news/health-31586074

THE HILL                        by Peter Sullivan                                                                 Feb. 20, 2015

WASHINGTON -- The Obama administration on Friday announced around $200 million in new funding to increase Ebola preparedness in the United States. 

The Department of Health and Human Services is giving grants to states to help set up 10 regional Ebola treatment centers, as well as hospitals in every state that can safely care for an Ebola patient until he or she is transferred. Combined with other funds, the move brings the total for local Ebola preparedness to around $340 million.

"Important lessons were also learned during the response effort," HHS said in a statement Friday. "Safety of health care workers must be foremost in health care system preparedness and response activities."

Read complete story.
http://thehill.com/policy/healthcare/233385-hhs-announces-new-funding-for-us-ebola-preparedness